Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00395 (long intergenic non-protein coding RNA 395) is a human gene annotated as a lncRNA, located on chromosome 13q21 at the position 63,667,677-63,742,822 on the reverse strand[3]. LINC00395 does not encode a protein and is classified among long intergenic non-protein coding RNAs, a diverse group of regulatory RNA molecules that can act in gene expression, chromatin structure, and other cellular processes, but no specific biological or clinical role is established for this locus according to current databases and scientific literature[1][3][5]. There is currently no evidence in cited sources suggesting LINC00395 is involved in disease mechanisms, is used as a biomarker, or is a direct target for drug therapy.
None (No mechanisms of action are relevant, because no drugs or therapies are known to target LINC00395[1][3][5].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 395 (LINC00395).